EDN1 and pulmonary arterial hypertension: ET-1 is thus an endogenous peptide with a role in the pathophysiology of pulmonary arterial hypertension and other pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis [14,15,16,17,18].